Glenmark Pharmaceuticals has informed that it has enclosed a media release on 27th May 2020 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Chlorzoxazone Tablets USP, 375 mg and 750 mg; Glenmark’s first ANDA approval out of their new US facility’.
The above information is a part of company’s filings submitted to BSE.